Log In
Print
BCIQ
Print
Print this Print this
 

NPSP795, SB-423562

  Manage Alerts
Collapse Summary General Information
Company NPS Pharmaceuticals Inc.
DescriptionSmall molecule antagonist of the calcium receptor
Molecular Target Calcium sensing receptor (CaSR)
Mechanism of ActionCalcium-sensing receptor (CaSR) antagonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard Indication Metabolic (unspecified)
Indication DetailsTreat autosomal dominant hypocalcaemia with hypercalciuria (ADHH); Treat autosomal dominant hypocalcemia (ADH)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today